The pharmaceutical giant Pfizer said on Monday that it had struck a $160 billion deal, including debt, to merge with Allergan, the maker of Botox, in one of the biggest takeovers in the health care industry.
The agreement would also be the biggest deal in what has been a banner year for mergers, driven in part by consolidation in the health care and pharmaceutical sectors. Merger and acquisition activity worldwide surpassed $4 trillion as of Thursday, for only the second time since Thomson Reuters began...
02:11 Murdoch Pounces on Sky as Lower Pound Makes Takeover Cheaper8
19:33 Russia signs Rosneft deal with Qatar, Glencore14
07:49 Murdoch's Twenty-First Century Fox Bids $14 Billion For UK's Sky11
19:34 CEO shift at Coca-Cola could usher in more dealmaking to refresh soda giant's growth13